Investment Rating - The report assigns a "BUY" rating for Pentamaster (01665.HK) [3] Target Price - The target price is set at HK 0.95 [4][20] Current Price and Market Capitalization - The current price is HK 1.5 billion [5][7] Revenue and Profitability - Pentamaster recorded a revenue of MYR 150.1 million in Q3 2024, reflecting a 16.9% year-over-year decline, leading to a 5.9% decrease in revenue for the first nine months of 2024 [18] - The gross profit for 2023 is reported at MYR 209.6 million, with projections of MYR 187.3 million for 2024 and MYR 212.8 million for 2025 [10][26] - The gross margin is expected to improve from 28.8% in Q3 2024 to 31.0% by 2026 [11][20] Segment Performance - The medical segment achieved stable revenue of MYR 79.0 million, expected to grow due to increased automation and contributions from single-use medical devices [19] - The automotive segment generated MYR 32.6 million in Q3 2024, but faced challenges due to cautious customer spending and macroeconomic uncertainties [19] Financial Projections - Revenue projections for the upcoming years are MYR 651.2 million for 2024, MYR 735.0 million for 2025, and MYR 806.2 million for 2026, indicating a recovery trend [9][26] - Profit attributable to shareholders is projected to be MYR 117.7 million in 2024, with an expected increase to MYR 161.8 million by 2026 [12][26] Performance Metrics - The return on equity (ROE) is projected to decline from 18.0% in 2023 to 13.1% in 2024, before gradually improving to 14.2% by 2026 [13][26] - The company has experienced a significant decline in stock performance, with a 30.3% drop over the past year [15] Market Context - The report highlights macroeconomic uncertainties as a primary obstacle affecting the company's performance and outlook [20] - The automotive segment's recovery remains weak, influenced by political issues in the US and policy uncertainties [19][20]
槟杰科达：Macro uncertainties remain the primary obstacle